As a kind of novel marker for malignant tumors, lncRNAs can modulate metabolism-related genes (c-MYC, ASS1, mTORC1), and further exert complex impacts on tumor progression, which expands our understanding of cancer metabolism. The gene discussed is MYC; the disease is cancer.